Edition:
United States

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

106.88USD
10:32am EST
Change (% chg)

$1.25 (+1.18%)
Prev Close
$105.63
Open
$106.32
Day's High
$107.05
Day's Low
$106.32
Volume
6,506
Avg. Vol
101,969
52-wk High
$119.03
52-wk Low
$86.25

Chart for

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 0.72
Market Cap(Mil.): $5,009.92
Shares Outstanding(Mil.): 47.43
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 192.73 16.31
EPS (TTM): -- -- --
ROI: -- -0.67 35.74
ROE: -- -3.38 17.71

BRIEF-Charles River Laboratories Q4 GAAP Loss Per Share $0.63

Feb 13 Charles River Laboratories International Inc:

Feb 13 2018

BRIEF-Charles River Laboratories International Board Size Increases From Ten To Eleven​

Jan 16 Charles River Laboratories International Inc:

Jan 16 2018

BRIEF-Charles River Laboratories Acquires KWS Biotest for GBP 15 Mln

Jan 11 Charles River Laboratories International Inc:

Jan 11 2018

BRIEF-Charles River Laboratories reports Q3 non-GAAP EPS of $1.30

Nov 9 Charles River Laboratories International Inc:

Nov 09 2017

BRIEF-Charles River announces expansion of in vitro oncology services

Oct 26 Charles River Laboratories International Inc

Oct 26 2017

Earnings vs. Estimates